Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5814-5825
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Figure 2 Expression of Wnt1-inducible signaling pathway protein 1 at the mRNA and protein levels is upregulated in gastric cancer patients.
A: Western blot analysis showed the expression of Wnt1-inducible signaling pathway protein 1 (WISP1) at the protein level in 20 samples; B: Negative expression of WISP1 in gastric cancer by immunohistochemical staining; C: Positive expression of WISP1 in gastric cancer by immunohistochemical staining; D: Statistical results of WISP1 expression at the mRNA level in 20 samples; E: Statistical results of WISP1 expression at the protein level in 20 samples; F: Statistic results of the immunohistochemical staining for WISP1 at the protein level in 20 samples. WISP1: Wnt1-inducible signaling pathway protein 1.
- Citation: Zhang LH, Wang Y, Fan QQ, Liu YK, Li LH, Qi XW, Mao Y, Hua D. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. World J Gastroenterol 2019; 25(38): 5814-5825
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5814